DEERFIELD MANAGEMENT COMPANY, L.P. Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$2.4T
Holdings
101
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (101 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —HORIZON PHARMA PLC | 8,956,988 | $144.9B | 5.96% | |
| 2 | —NXSTAGE MEDICAL INC | 4,258,196 | $111.6B | 4.59% | |
| 3 | —AVEXIS INC | 2,236,701 | $106.8B | 4.39% | |
| 4 | —PORTOLA PHARMACEUTICALS INC | 4,654,447 | $104.4B | 4.30% | |
| 5 | —GW PHARMACEUTICALS PLC | 928,192 | $103.7B | 4.27% | |
| 6 | —MYLAN N V | 2,216,378 | $84.6B | 3.48% | Call |
| 7 | —HORIZON PHARMA INVT LTD | 82,600,000 | $78.3B | 3.22% | |
| 8 | AERIEURAERIE PHARMACEUTICALS INC | 1,838,829 | $69.6B | 2.86% | |
| 9 | —ARRAY BIOPHARMA INC | 45,000,000 | $62.5B | 2.57% | |
| 10 | —DBV TECHNOLOGIES S A | 1,743,229 | $61.2B | 2.52% | |
| 11 | VNDAVANDA PHARMACEUTICALS INC | 3,424,676 | $54.6B | 2.25% | |
| 12 | NVROEURNEVRO CORP | 751,298 | $54.6B | 2.25% | |
| 13 | XNCRXENCOR INC | 2,020,000 | $53.2B | 2.19% | |
| 14 | 2L9BLUEPRINT MEDICINES CORP | 1,842,415 | $51.7B | 2.13% | |
| 15 | —ENDOLOGIX INC | 51,117,000 | $46.1B | 1.90% | |
| 16 | ELVANTHEM INC | 318,000 | $45.7B | 1.88% | |
| 17 | LN5LANNET INC | 2,007,551 | $44.3B | 1.82% | |
| 18 | —FLAMEL TECHNOLOGIES SA | 4,072,809 | $42.3B | 1.74% | |
| 19 | —WRIGHT MED GROUP INC | 40,050,000 | $41.8B | 1.72% | |
| 20 | TRIB 4 04/01/45TRINITY BIOTECH INVT LTD | 48,000,000 | $40.4B | 1.66% | |
| 21 | HUMHUMANA INC | 198,000 | $40.4B | 1.66% | |
| 22 | —UNIVERSAL AMERN CORP NEW | 3,774,090 | $37.6B | 1.55% | |
| 23 | —ENDOLOGIX INC | 40,500,000 | $35.4B | 1.46% | |
| 24 | CNCCENTENE CORP DEL | 603,643 | $34.1B | 1.40% | |
| 25 | —ISIS PHARMACEUTICALS INC DEL | 33,186,000 | $33.8B | 1.39% | |
| 26 | —HEALTHWAYS INC | 25,000,000 | $32.4B | 1.33% | |
| 27 | —AETNA INC NEW | 242,000 | $30.0B | 1.23% | |
| 28 | —NEVRO CORP | 27,600,000 | $29.5B | 1.21% | |
| 29 | WBAWALGREENS BOOTS ALLIANCE INC | 355,957 | $29.5B | 1.21% | |
| 30 | —MOLINA HEALTHCARE INC | 25,000,000 | $28.5B | 1.17% | |
| 31 | EHTHEHEALTH INC | 2,640,609 | $28.1B | 1.16% | |
| 32 | EDITEDITAS MEDICINE INC | 1,709,400 | $27.7B | 1.14% | |
| 33 | GLPGGALAPAGOS NV | 423,112 | $27.2B | 1.12% | |
| 34 | GMEDGLOBUS MED INC | 1,036,000 | $25.7B | 1.06% | |
| 35 | —AUDENTES THERAPEUTICS INC | 1,403,653 | $25.6B | 1.06% | |
| 36 | —SYROS PHARMACEUTICALS INC | 1,812,778 | $22.0B | 0.91% | |
| 37 | ASNDASCENDIS PHARMA A S | 1,050,000 | $21.3B | 0.87% | |
| 38 | BCRXBIOCRYST PHARMACEUTICALS | 3,237,734 | $20.5B | 0.84% | |
| 39 | —MALLINCKRODT PUB LTD CO | 407,000 | $20.3B | 0.83% | |
| 40 | —EPIZYME INC | 1,601,049 | $19.4B | 0.80% | |
| 41 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 27,715,000 | $19.2B | 0.79% | |
| 42 | —BLUEBIRD BIO INC | 302,027 | $18.6B | 0.77% | |
| 43 | —MYOVANT SCIENCES LTD | 1,496,675 | $18.6B | 0.77% | |
| 44 | —CLOVIS ONCOLOGY INC | 16,500,000 | $17.0B | 0.70% | |
| 45 | SCTLRECRO PHARMA INC | 2,075,000 | $16.7B | 0.69% | |
| 46 | AXGNAXOGEN INC | 1,838,225 | $16.5B | 0.68% | |
| 47 | ZBHZIMMER BIOMET HLDGS INC | 150,000 | $15.5B | 0.64% | |
| 48 | —TESARO INC | 112,200 | $15.1B | 0.62% | |
| 49 | SELBUSDSELECTA BIOSCIENCES INC | 853,205 | $14.6B | 0.60% | |
| 50 | ARRYEURARRAY BIOPHARMA INC | 1,650,000 | $14.5B | 0.60% | |
| 51 | —AAC HLDGS INC | 1,975,347 | $14.3B | 0.59% | |
| 52 | —SPARK THERAPEUTICS INC | 283,000 | $14.1B | 0.58% | |
| 53 | —FOAMIX PHARMACEUTICALS LTD | 1,232,844 | $13.7B | 0.56% | |
| 54 | GKOSGLAUKOS CORP | 393,228 | $13.5B | 0.55% | |
| 55 | —KITE PHARMA INC | 297,902 | $13.4B | 0.55% | |
| 56 | WVEWAVE LIFE SCIENCES LTD | 472,124 | $12.3B | 0.51% | |
| 57 | —ADEPTUS HEALTH INC | 1,600,861 | $12.2B | 0.50% | |
| 58 | CTMXCYTOMX THERAPEUTICS INC | 943,433 | $10.4B | 0.43% | |
| 59 | ISIIONIS PHARMACEUTICALS INC | 214,095 | $10.2B | 0.42% | |
| 60 | ACRSACLARIS THERAPEUTICS INC | 375,000 | $10.2B | 0.42% | |
| 61 | —INVUITY INC | 1,690,498 | $9.7B | 0.40% | |
| 62 | —NIVALIS THERAPEUTICS INC | 3,732,412 | $8.4B | 0.34% | |
| 63 | —AKARI THERAPEUTICS PLC | 1,150,700 | $8.1B | 0.33% | |
| 64 | —LOXO ONCOLOGY INC | 251,000 | $8.1B | 0.33% | |
| 65 | —OXFORD IMMUNOTEC GLOBAL PLC | 529,197 | $7.9B | 0.33% | |
| 66 | —KERYX BIOPHARMACEUTICALS INC | 1,291,531 | $7.6B | 0.31% | |
| 67 | —ARALEZ PHARMACEUTICALS INC | 1,644,583 | $7.3B | 0.30% | |
| 68 | —AXOVANT SCIENCES LTD | 568,005 | $7.1B | 0.29% | |
| 69 | —FIVE PRIME THERAPEUTICS INC | 138,000 | $6.9B | 0.28% | |
| 70 | EXASEXACT SCIENCES CORP | 500,000 | $6.7B | 0.27% | |
| 71 | —ALIMERA SCIENCES INC | 5,878,015 | $6.3B | 0.26% | |
| 72 | —ADVANCED ACCELERATOR APPLIC | 210,000 | $5.6B | 0.23% | |
| 73 | —MYOKARDIA INC | 424,800 | $5.5B | 0.23% | |
| 74 | ARDXARDELYX INC | 373,643 | $5.3B | 0.22% | |
| 75 | —CAS MED SYS INC | 3,200,000 | $5.2B | 0.21% | |
| 76 | —RA PHARMACEUTICALS INC | 323,630 | $4.9B | 0.20% | |
| 77 | —ESSA PHARMA INC | 2,121,601 | $4.6B | 0.19% | |
| 78 | —STEADYMED LTD | 1,756,370 | $4.6B | 0.19% | |
| 79 | SCYXEURSCYNEXIS INC | 1,048,000 | $3.3B | 0.14% | |
| 80 | —KEMPHARM INC | 1,084,443 | $3.2B | 0.13% | |
| 81 | NSTGEURNANOSTRING TECHNOLOGIES INC | 139,000 | $3.1B | 0.13% | |
| 82 | VYGRVOYAGER THERAPEUTICS INC | 235,294 | $3.0B | 0.12% | |
| 83 | —GENOCEA BIOSCIENCES INC | 687,257 | $2.8B | 0.12% | |
| 84 | GBYSANGAMO BIOSCIENCES INC | 837,963 | $2.6B | 0.11% | |
| 85 | —PSIVIDA CORP | 1,492,824 | $2.6B | 0.11% | |
| 86 | —PROTEON THERAPEUTICS INC | 1,332,599 | $2.5B | 0.10% | |
| 87 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 171,428 | $2.5B | 0.10% | |
| 88 | —CATABASIS PHARMACEUTICALS IN | 682,940 | $2.5B | 0.10% | |
| 89 | —PROTEOSTASIS THERAPEUTICS IN | 186,000 | $2.3B | 0.09% | |
| 90 | —AGILE THERAPEUTICS INC | 398,000 | $2.3B | 0.09% | |
| 91 | —CELLDEX THERAPEUTICS INC NEW | 632,944 | $2.2B | 0.09% | |
| 92 | —BIOSCRIP INC | 1,971,228 | $2.0B | 0.08% | |
| 93 | —PRONAI THERAPEUTICS INC | 1,166,619 | $1.7B | 0.07% | |
| 94 | —HEALTHWAYS INC | 76,000 | $1.7B | 0.07% | |
| 95 | —PARATEK PHARMACEUTICALS INC | 100,000 | $1.5B | 0.06% | |
| 96 | —NOVELION THERAPEUTICS INC | 170,454 | $1.4B | 0.06% | |
| 97 | —NEOS THERAPEUTICS INC | 229,166 | $1.3B | 0.06% | |
| 98 | —OCERA THERAPEUTICS INC | 572,893 | $1.2B | 0.05% | |
| 99 | —THRESHOLD PHARMACEUTICAL INC | 2,202,160 | $971.0M | 0.04% | |
| 100 | —STREAMLINE HEALTH SOLUTIONS | 662,971 | $829.0M | 0.03% |
Page 1 of 2Next